FDA’s Draft Guidance on Dosage Optimization for Oncology Therapeutic Radiopharmaceuticals: Implications for Clinical Development
FDA’s Draft Guidance on Dosage Optimization for Oncology Therapeutic Radiopharmaceuticals: Implications for Clinical Development
7 PagesThis brief explores the growing role of radiopharmaceuticals in oncology and precision medicine, highlighting scientific innovation, clinical potential, and commercialization challenges. It addresses supply chain complexity, regulatory considerations, manufacturing constraints, and site readiness. IQVIA outlines how integrated data, advanced analytics, and cross-functional planning help organizations accelerate development and adoption. The brief emphasizes the importance of early market preparation, ecosystem partnerships, and real-world evidence to unlock the full value of radiopharmaceutical therapies.
